113 - Optimizing Molecular Testing in Algorithms for the Diagnosis of Challenging Fungal Pathogens

Friday, October 1, 2021

4:15 PM - 5:30 PM EDT

Moderator(s)

Karen Carroll, MD

Professor, Director, Division Medical Microbiology
Johns Hopkins University School of Medicine
Baltimore, MD, United States

Pattern Diagnostics, Inc. (Individual(s) Involved: Self): Grant/Research Support; Scanogen, Inc. (Individual(s) Involved: Self): Consultant
Marjorie Bateman, MD

Pulmonary and Critical Care Fellow
Brigham and Women's Hospital
Boston, MA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

Marjorie Bateman, MD

Pulmonary and Critical Care Fellow
Brigham and Women's Hospital
Boston, MA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sean Zhang, MD, PhD

Associate Professor
Johns Hopkins
Baltimore, MD, United States

IMMY diagnostics (Individual(s) Involved: Self): Research Grant or Support; Vela diagnostics (Individual(s) Involved: Self): Research Grant or Support
Alexandre Alanio, MD, PhD

Professor
Université de Paris
Paris

Astellas (Individual(s) Involved: Self): Research Grant or Support; GIlead (Individual(s) Involved: Self): Other Financial or Material Support, Personnal fees for education; Pfizer (Individual(s) Involved: Self): Board Member

Participants should be aware of the following financial/non-financial relationships:

Karen C. Carroll, MD: Pattern Diagnostics, Inc. (Individual(s) Involved: Self): Grant/Research Support; Scanogen, Inc. (Individual(s) Involved: Self): Consultant

Marjorie E. Bateman, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Sean Zhang, MD, PhD: IMMY diagnostics (Individual(s) Involved: Self): Research Grant or Support; Vela diagnostics (Individual(s) Involved: Self): Research Grant or Support

Alexandre Alanio, MD, PhD: Astellas (Individual(s) Involved: Self): Research Grant or Support; GIlead (Individual(s) Involved: Self): Other Financial or Material Support, Personnal fees for education; Pfizer (Individual(s) Involved: Self): Board Member

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE credits

Learning Objectives:

At the conclusion of this session, participants will be able to:

compare the characteristics of diagnostic molecular tests for Pneumocystis jirovecii and describe barriers that need to be addressed prior to widespread clinical implementation
explain the advances and challenges in the molecular diagnosis of mucormycosis
describe the utility of molecular tools including NGS for the direct genus/species level identification of fungal pathogens in FFPE tissues

Presentations:

Diagnostic Molecular Tests for Pneumocystis jirovecii
Speaker: Marjorie E. Bateman, MD – Brigham and Women's Hospital
Direct from Tissue Fungal Sequencing
Speaker: Sean Zhang, MD, PhD – Johns Hopkins
Molecular Diagnosis of Mucormycosis
Speaker: Alexandre Alanio, MD, PhD – Université de Paris